Myovant Sciences

-$0.17 (-0.87%) Today
+$0.01 (+0.05%) As of 11:00 AM UTC after-hours

Why Robinhood?

You can buy or sell MYOV and other stocks, options, and ETFs commission-free!

About MYOV

Myovant Sciences Ltd., also called Myovant Sciences, is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing therapies for the treatment of women's health and endocrine diseases.

CEO
David C. Marek
Employees
214
Headquarters
London, Greater London
Founded
2016

MYOV Key Statistics

Market Cap
1.85B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
576.21K
High Today
$19.68
Low Today
$18.80
Open Price
$19.28
Volume
390.05K
52 Week High
$30.90
52 Week Low
$11.55

MYOV Earnings

-$0.99
-$0.66
-$0.33
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
-$0.99 per share
Actual
Available May 11, Pre-Market

You May Also Like

AKUS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure